BAKER G LEONARD JR 4

4 · CORCEPT THERAPEUTICS INC · Filed Mar 19, 2026

AI-generated summary of this filing

Updated Mar 19, 2026

Corcept (CORT) Director Baker G. Leonard Jr Buys 100,000 Shares

What Happened

Baker G. Leonard Jr, a director of Corcept Therapeutics (CORT), made two open-market purchases on 2026-03-17 totaling 100,000 shares. He acquired 75,782 shares at a weighted average price reported as $33.00 (total $2,500,973) and 24,218 shares at a weighted average price reported as $33.56 (total $812,836). Aggregate transaction value ≈ $3,313,809. These were purchases (insider buys), which investors often view as a more informative/bullish signal than routine sales.

Key Details

Transaction date: 2026-03-17; Form 4 filed: 2026-03-19 (filed within the typical 2-business-day window).
Prices: first lot weighted avg $33.00 (actual trades ranged $32.43–$33.30); second lot weighted avg $33.56 (actual trades ranged $33.44–$33.68). Reporting person can provide breakdown of quantities at each price on request (footnotes F1, F2).
Shares owned after transaction: not disclosed in the provided excerpt of the Form 4.
Footnotes of note: F1/F2 explain weighted-average prices and ranges; F3/F4 note certain shares are held by entities (limited partnership/trust) for which the reporting person is a trustee and disclaims beneficial ownership except for pecuniary interest.
Transaction code: P = Purchase (open market/private purchase).

Context

This filing documents open-market purchases by a company director; purchases are factual signals of buying activity but do not by themselves explain motivation. The filing appears timely (no late-filing indication).

Form 4

Period: 2026-03-17

Director

Transactions

Purchase
Common Stock
[F1]
2026-03-17$33.00/sh+75,782$2,500,973→ 1,122,413 total
Purchase
Common Stock
[F2]
2026-03-17$33.56/sh+24,218$812,836→ 1,146,631 total

Holdings

Footnotes (4)

[F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.43 to $33.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
[F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.44 to $33.68 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
[F3]Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
[F4]Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Signature

/s/ Kanwalpreet S. Kalra, by power of attorney|2026-03-19

1 file